Incidence and Pattern of Aminotransferase Elevation During Anti-Hypertensive Therapy With Angiotensin-II Receptor Blockers-Reference-Cited by-同舟云学术

Incidence and Pattern of Aminotransferase Elevation During Anti-Hypertensive Therapy With Angiotensin-II Receptor Blockers

Published:2022 Issue:33 Volume:37 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Choi Won Joon¹^ORCID,Kim Gi-Ae²^ORCID,Park Jaewon¹^ORCID,Jang Sangmi¹^ORCID,Jung Woo Jin¹^ORCID,Shim Jae-Jun²^ORCID,Park Yewan²^ORCID,Choi Gwang Hyeon¹^ORCID,Kim Jin-Wook¹^ORCID,Jeong Sook-Hyang¹^ORCID,Jang Eun Sun¹^ORCID

Affiliation:

1. Department of Internal Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.

2. Department of Internal Medicine, Kyung Hee University Medical Center, Seoul, Korea.

Publisher

Korean Academy of Medical Sciences

Subject

General Medicine

Link

https://jkms.org/pdf/10.3346/jkms.2022.37.e255

Reference23 articles.

1. Cardiovascular risk reduction in hypertension: angiotensin-converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to?

2. Reports and Data. Angiotensin II receptor blockers market analysis, by type (Azilsartan, Candesartan, Eprosartan, Irbesartan, Losartan, Olmesartan, Telmisartan, Valsartan) by application (Hypertension, Cardiovascular risks) forecasts to 2028. Updated 2021. Accessed April 8, 2022. https://www.reportsanddata.com/report-detail/angiotensin-ii-receptor-blockers-market

3. The Korean Society of Hypertension - Hypertension Epidemiology Research Working Group. Korea hypertension fact sheet 2021. Updated 2021. Accessed April 8, 2022. https://www.koreanhypertension.org/reference/guide?mode=read&idno=4581

4. Losartan. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda, MD, USA. National Institute of Diabetes and Digestive and Kidney Diseases. 2012-. Updated 2017. Accessed April 8, 2022. https://www.ncbi.nlm.nih.gov/books/NBK547842

5. Valsartan. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda, MD, USA. National Institute of Diabetes and Digestive and Kidney Diseases. 2012-. Updated 2017. Accessed April 8, 2022. https://www.ncbi.nlm.nih.gov/books/NBK547944

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New exploration of signal detection of Regional Risks from the perspective of data mining: a pharmacovigilance analysis based on spontaneous reporting data in Zhenjiang, China;Expert Opinion on Drug Safety;2023-11-27

2. Two-Drug Combinations Therapy of Different Doses of Valsartan Existing Diverse Significance for Hypertensive Patients;Reviews in Cardiovascular Medicine;2023-06-29

3. Physiologically based pharmacokinetic modeling of candesartan to predict the exposure in hepatic and renal impairment and elderly populations;Therapeutic Advances in Drug Safety;2023-01

4. Are Angiotensin II Receptor Blockers Really Safe From Aminotransferase Elevation or Drug-Induced Liver Injury?;Journal of Korean Medical Science;2022